![]() |
Volumn 20, Issue 1, 2010, Pages 56-59
|
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers
|
Author keywords
Curcumin; Enoyl ACP reductase (ENR); Escherichia coli; FabI; Luteolin
|
Indexed keywords
CHLORAMPHENICOL;
CURCUMIN;
ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH);
ENZYME INHIBITOR;
ERYTHROMYCIN;
GENISTEIN;
GENTAMICIN;
LUTEOLIN;
PENTOSALEN;
POLYDATIN;
RIFAMPICIN;
SPECTINOMYCIN;
TRICLOSAN;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL STRAIN;
CHINESE MEDICINE;
CONTROLLED STUDY;
DRUG SCREENING;
ENZYME ACTIVITY;
ENZYME INHIBITION;
ESCHERICHIA COLI;
GENE OVEREXPRESSION;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
ANTI-BACTERIAL AGENTS;
BINDING SITES;
COMPUTER SIMULATION;
CURCUMIN;
ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH);
ESCHERICHIA COLI;
ESCHERICHIA COLI PROTEINS;
LUTEOLIN;
MEDICINE, CHINESE TRADITIONAL;
ESCHERICHIA COLI;
|
EID: 72049128855
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2009.11.042 Document Type: Article |
Times cited : (17)
|
References (26)
|